CDNA Surveillance Case Definitions Working Group
National list | Implementation | State and Territories list | Acknowledgements
Revised case definitions for nationally notifiable diseases
A working group of CDNA was convened in 2001 to revise or develop standard case definitions for all nationally notifiable diseases for reporting to the Commonwealth. The new case definitions will be implemented nationally from January 2004. The Surveillance Case Definitions have been developed through a consensus approach in a series of teleconferences undertaken progressively over the last two years. The Working Group comprised members representing all State and Territory jurisdictions, the Commonwealth Department of Health and Ageing, the Public Health Laboratory Network (PHLN), OzFoodNet, the National Centre in HIV Epidemiology and Clinical Research (NCHECR), and the National Centre for Immunisation Research and Surveillance. Laboratory definitions previously developed by the PHLN formed the basis for the Surveillance Case Definitions, with clinical and epidemiologic elements added, as appropriate.
In the revised Surveillance Case Definitions, clinical, laboratory and epidemiological evidence is specified separately for each definition, where relevant, to provide a consistent format. A number of diseases are now notified as either 'confirmed' or 'probable' according to the certainty of the diagnosis. Descriptions for both confirmed and probable cases are provided within relevant case definitions.
In November 2002, CDNA decided to add a further two new diseases to the national list: tularemia, and smallpox. There are now 64 diseases or syndromes that are nationally notifiable. The disease code for each disease or syndrome reported to the National Notifiable Diseases Surveillance System (NNDSS) is provided in the Table 1. During the process of formulating case definitions the names of some listed diseases or syndromes were modified, to more accurately reflect cases collected in the category.
The disease list includes HIV and AIDS, which are not reported via NNDSS, but are sent directly to NCHECR from state and territory health departments.
In the new list, syphilis (formerly disease code 032) has been segregated into two new categories. Two new disease codes have been assigned:
- 'Syphilis -infectious (primary, secondary and early latent), less than 2 years duration' (code 066) and;
- 'Syphilis -more than 2 years or unknown duration' (code 067).
Cases of HIV reported to the NCHECR are categorised as either:
- HIV -newly acquired;
- HIV -unspecified -individuals 18 months of age or older; or
- HIV -unspecified -children less than 18 months of age
Top of page
Table 1. List of nationally notifiable diseases, Australia, 2004
Number | Disease/syndrome name | Disease code |
---|---|---|
1 | Acquired immunodeficiency syndrome (AIDS) | Sent to NCHECR |
2 | Anthrax | 058 |
3 | Ross River virus | 002 |
4 | Barmah Forest virus | 048 |
5 | Dengue | 003 |
6 | Japanese encephalitis | 059 |
7 | Kunjin virus | 060 |
8 | Murray Valley encephalitis | 049 |
9 | Flavivirus infection —unspecified or not otherwise classified | 001 |
10 | Botulism | 045 |
11 | Brucellosis | 004 |
12 | Campylobacteriosis | 005 |
13 | Chlamydia | 007 |
14 | Cholera | 008 |
15 | Cryptosporidiosis | 061 |
16 | Diphtheria† | 009 |
17 | Donovanosis† | 010 |
18 | Gonococcal infection | 011 |
19 | Haemolytic uraemic syndrome | 055 |
20 | Haemophilus Influenzae serotype B (Hib) infection (invasive) | 012 |
21 | Viral haemorrhagic fevers† | 036 |
22 | Hepatitis A† | 038 |
23 | Hepatitis B —newly acquired | 039 |
24 | Hepatitis B —unspecified | 052 |
25 | Hepatitis C —newly acquired | 040 |
26 | Hepatitis C —unspecified | 053 |
27 | Hepatitis D | 050 |
28 | Hepatitis E | 051 |
29 | Viral hepatitis (not otherwise specified) | 037 |
30 | HIV —newly acquired† | Sent to NCHECR |
31 | HIV —unspecified —individuals 18 months of age or older† | Sent to NCHECR |
32 | HIV —unspecified —children less than 18 months of age† | Sent to NCHECR |
33 | Influenza —laboratory-confirmed | 062 |
34 | Legionellosis† | 015 |
35 | Leprosy (Hansen's disease) | 016 |
36 | Leptospirosis | 017 |
37 | Listeriosis | 018 |
38 | Lyssavirus —Australian bat lyssavirus (ABL) | 063 |
39 | Lyssavirus —rabies | 028 |
40 | Lyssavirus —unspecified | 064 |
41 | Malaria | 020 |
42 | Measles† | 021 |
43 | Invasive meningococcal disease† | 022 |
44 | Mumps | 043 |
45 | Psittacosis (ornithosis)† | 023 |
46 | Pertussis† | 024 |
47 | Plague | 025 |
48 | Poliomyelitis (wild type and vaccine associated)† | 026 |
49 | Pneumococcal disease (invasive) | 065 |
50 | Q fever | 027 |
51 | Rubella† | 029 |
52 | Congenital rubella syndrome† | 046 |
53 | Salmonellosis | 030 |
54 | Shigellosis | 031 |
55 | Shiga-toxin producing E. coli —VTEC/STEC | 054 |
56 | Syphilis —infectious (primary, secondary and early latent), less than 2 years duration | 066 |
57 | Syphilis —more than 2 years or unknown duration | 067 |
58 | Congenital syphilis† | 047 |
59 | Tetanus | 033 |
60 | Tuberculosis | 034 |
61 | Typhoid | 035 |
62 | Yellow fever | 041 |
64 | Smallpox | 069 |
65 | Tularemia | 070 |
* Reported to NNDSS via ANCJDR, or State or Territory health departments
† Probable and confirmed cases defined
Disease codes in bold indicate a new code number
Implementation
While acknowledging that public health legislation in individual jurisdictions may have to be revised to cover the collection of the new diseases added to the list, the new case definitions will be implemented for all diseases from 1 January 2004, for reporting to the Commonwealth. Details of the interim case definitions are available from the Communicable Diseases Australia website: http://www.health.gov.au/internet/main/publishing.nsf/Content/Case+definitions-1.
Other notifiable conditions
In addition to the diseases that are reported to NNDSS at the Department of Health and Ageing, each jurisdiction may have other diseases/syndromes/conditions that are required by public health legislation to be notified to the state or territory health department. Diseases, syndromes and conditions that are notifiable in each state or territory, in addition to the national list, are listed in Table 2.
Table 2. Additional conditions required to be notified in each State or Territory
Australian Capital Territory |
---|
Chancroid |
Equine morbillivirus (Hendra virus) infection |
Giardiasis |
Lymphogranuloma venereum |
Yersiniosis |
New South Wales |
Adverse event following immunisation |
Chancroid |
Foodborne illness in 2 or more related cases |
Gastroenteritis among people of any age, in an institution (e.g. among persons in educational or residential institutions) |
Lymphogranuloma venereum |
Typhus (epidemic) |
Northern Territory |
Acute post-streptococcal glomerulonephritis |
Acute rheumatic fever |
Adverse event following immunisation |
Amoebiasis |
Atypical mycobacterial disease or non-tuberculous mycobacteria (NTM) |
Chancroid |
Chlamydial conjunctivitis |
Echinococcosis (hydatid disease) |
Gastroenteritis (with potential for outbreak): water
or foodborne diseases in:
two or more related cases |
Human T-cell lymphotropic virus |
Lymphogranuloma venereum |
Melioidosis |
Rotavirus infection |
Thrombotic thrombocytopaenia purpura |
Trichomoniasis |
Typhus (all forms) |
Vibrio food poisoning |
Yersiniosis |
Queensland |
Acute flaccid paralysis |
Acute rheumatic fever |
Adverse event following immunisation |
Atypical mycobacterial disease |
Bunyavirus infections (not included in arbovirus NEC) |
Chancroid |
Ciguatera poisoning |
Cryptococcus |
Echinococcosis (hydatid disease) |
Elevated lead levels |
Equine morbillivirus (Hendra virus) infection |
Foodborne or waterborne disease in 2 or more related cases |
Hendra virus infection |
Lymphogranuloma venereum |
Melioidosis |
Yersiniosis |
South Australia (Available at http://www.dhs.sa.gov.au/pehs/topics/topic-notifiable-diseases.htm) |
Atypical mycobacterial disease |
Echinococcosis (hydatid disease) |
Varicella-zoster infection (chickenpox and shingles) |
Yersiniosis |
Tasmania (Available at http://www.dhhs.tas.gov.au/publichealth/communicablediseases/) |
Amoebiasis |
Chancroid |
Echinococcosis (hydatid disease) |
Elevated lead levels |
Gastroenteritis in an institution i.e. residential, educational or child care facility |
Giardiasis |
Lymphogranuloma venereum |
Mycobacterial infection (including atypical Mycobacterium spp.) |
Rickettsial infection (including Flinders Island spotted fever and others) |
Suspected cases of food and waterborne illnesses |
Taeniasis |
Typhus epidemic (Rickettsia prowazekii) |
Vancomycin resistant enterococci |
Vibrio infection |
Yersiniosis |
Victoria |
Food and waterborne illness in two or more related cases |
Giardiasis |
Western Australia |
Adverse events following immunisation |
Amoebiasis |
Amoebic meningitis |
Chancroid |
Echinococcosis (hydatid disease) |
Giardiasis |
Melioidosis |
Methicillin-resistant Staphyloccocus aureus infection |
Paratyphoid fever |
Relapsing fever |
Scarlet fever |
Schistosomiasis (Bilharzia) |
Typhus (Rickettsial infection) |
Vibrio parahaemolyticus |
Yersiniosis |
Acknowledgments
The revision of the case definitions commenced in early 2001. The Surveillance Case Definitions working group was chaired by Robert Hall until August 2002, after which Gary Dowse took the lead. During this time contributors included:
Charles Guest, Louise Carter (Australian Capital Territory);
Jeremy McAnulty, Valerie Delpech, Kerry Todd (New South Wales);
Vicki Krause, Peter Markey (Northern Territory);
Linda Selvey, Robyn Pugh (Queensland);
Rob Hall, Rod Givney (South Australia):
Avner Misrachi, David Coleman (Tasmania);
Graham Tallis, Kerry Ann O'Grady, Sean Tobin (Victoria);
Gary Dowse (Western Australia);
Martyn Kirk (OzFoodNet);
John Kaldor, Anne McDonald (National Centre in HIV Epidemiology and Clinical Research);
Heather Gidding (National Centre for Immunisation Research and Surveillance);
David Smith, Dominic Dwyer, Mike Catton (Public Health Laboratory Network); and
Moira McKinnon, Jenean Spencer (Department of Health and Ageing)
The National Arbovirus Advisory Committee, the National Tuberculosis Advisory Committee, the STI Surveillance Committee and the Viral Hepatitis Surveillance Committee also provided valuable contributions. Laboratory case definitions were based on those developed by the Public Health Laboratory Network. Dr Sue Skull is acknowledged for her work collating State and Territory case definitions.
Peter Lindenmayer played a vital role in the planning and co-ordination of this complex process. Thanks also go to others in the CDNA secretariat, including Robyn Leader, Andrea Symons and Jane Tussup.
This article was published in Communicable Diseases Intelligence, Volume 28 No 1, March 2004.
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 28 No 1, March 2004
Communicable Diseases Intelligence